Jeff Geschwind, MD’s Global Research Impact Through NAMSA and USA Clinics Group, Jeff Geschwind, MD, leads international clinical trials, fast-tracking FDA-approved cancer therapies. His research translates lab discoveries into real-world patient benefits. https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/